The product will be showcased at the upcoming 34th Congress of the International Society for Advancement of Cytometry (CYTO) in Vancouver, Canada from June 22 to 26.
Over the last decade, scientists have advanced their understanding of immune cell function in many contexts, including cancer. Progress, however, has been slow because identification of immune cell functional signatures requires time consuming processes that average individual cell behaviors and interactions.
“Analysis of T cell function has largely been based on assessing the activity of an entire population of cells, which reduces the resolution of our results,” said Alan Ashworth, PhD, FRS, president of the Helen Diller Family Comprehensive Cancer Center. “Deeper insights are needed to let us see differences that enable us to draw more informed conclusions about T cell function. This will improve our understanding of cancer immunotherapeutics.”
The Lightning platform allows scientists to easily visualize phenotype and perform...
“With the new Lightning platform, scientists across the research and development pipeline, from academia to top pharmaceutical companies, can more precisely and quickly design, build, and test new assays to uncover the function of T cells, speeding their efforts to improve cancer immunotherapies,” said Eric Hobbs, CEO at Berkeley Lights, Inc. “Lightning is an agile desktop platform built for scientists who push the boundaries of individual cell analysis and we believe this is a key step in our goal of democratizing digital cell biology.”
Join Berkeley Lights at CYTO exhibit booth #102 to see the platform first hand.
About Berkeley Lights
Berkeley Lights, Inc. (BLI) is a digital cell biology company that develops and commercializes workflows and processes for the biotechnology sector to accelerate the design, discovery, development, and delivery of cell-based products. By operating at the intersection of biology, technology, and information, our workflows automate the manipulation, analysis, and selection of individual cells, creating ultimate scalability and deep cell insights. BLI enables the rapid deployment of biology for the production of sustainable and scalable sources of food, therapies, and energy.